» Articles » PMID: 22182378

Clinical Study of Psoriasis Occurring over the Age of 60 Years: is Elderly-onset Psoriasis a Distinct Subtype?

Overview
Journal Int J Dermatol
Specialty Dermatology
Date 2011 Dec 21
PMID 22182378
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous studies demonstrated clinical differences of early- and late-onset psoriasis. However, epidemiological data and clinical characteristics of psoriasis occurring in geriatric patients have been rarely studied.

Objective: Assessment of epidemiology and clinical features of psoriasis first occurring over the age of 60 years, so-called elderly-onset psoriasis, based on clinical data.

Materials And Methods: Among 4049 patients visiting our psoriasis clinic for the last 27 years, patients were first divided into early- (onset age before 30 years) and late-onset psoriasis (onset age after 30 years) based on our previous studies. Then, patients of late-onset psoriasis were further divided into middle age-onset group (onset age between 30 and 60 years) and elderly-onset group (onset age over 60 years). Clinical characteristics of elderly-onset psoriasis were compared with early- and middle age-onset groups. We acquired the data both by physician's assessments and patients' responses.

Results: Elderly-onset patients comprised 3.2% of total patients, 129 out of 4049. They have shown a lower incidence of family history (P < 0.05). The severity assessed by PASI score, body surface extent, and activity of individual lesions demonstrated that psoriasis of the elderly-onset group was generally milder compared with early- and middle age-onset groups (P < 0.05). In clinical phenotypes, the proportion of guttate type and generalized pustular psoriasis type decreased remarkably, while that of erythroderma type increased (P < 0.05). There was a significant change in the body part of origin comparing early- and middle age-onset groups (P < 0.05). The proportion of scalp increased, while that of knee-elbow and trunk decreased significantly (P < 0.05). Patients' subjective sensation of disease course improved statistically comparing early- and middle age-onset groups (P < 0.05). There was no significant change in the degree of pruritus on psoriatic lesions and nail involvement (P > 0.05).

Conclusion: The elderly-onset group demonstrated milder disease courses and some changes in clinical phenotypes and body part of origin compared with early- and middle age-onset groups. Therefore, it seems that patients whose onset of psoriasis was over the age of 60 years might have distinct clinical features in some clinical aspects.

Citing Articles

Skin Disease Profile in Geriatric Inpatients at a Tertiary Referral Hospital.

Legiawati L, Yusharyahya S, Astriningrum R, Pulungan A, Kusumahapsari R Malays J Med Sci. 2024; 30(6):54-60.

PMID: 38239249 PMC: 10793136. DOI: 10.21315/mjms2023.30.6.6.


Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks.

Ter Haar E, van den Reek J, Gaarn Du Jardin K, Barbero-Castillo A, de Jong E, Lubeek S Acta Derm Venereol. 2023; 103:adv17752.

PMID: 37877618 PMC: 10614651. DOI: 10.2340/actadv.v103.17752.


Immunosenescence and Skin: A State of Art of Its Etiopathogenetic Role and Crucial Watershed for Systemic Implications.

Papa V, Li Pomi F, Borgia F, Vaccaro M, Pioggia G, Gangemi S Int J Mol Sci. 2023; 24(9).

PMID: 37175661 PMC: 10178319. DOI: 10.3390/ijms24097956.


Early-Onset Versus Late-Onset Psoriasis: A Comparative Study of Clinical Variables, Comorbidities, and Association with HLA CW6 in a Tertiary Care Center.

Fatema F, Ghoshal L, Saha A, Agarwal S, Bandyopadhyay D Indian J Dermatol. 2022; 66(6):705.

PMID: 35283511 PMC: 8906303. DOI: 10.4103/ijd.ijd_45_21.


Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.

Ruggiero A, Fabbrocini G, Cinelli E, Ocampo Garza S, Camela E, Megna M Clin Exp Dermatol. 2021; 47(3):561-567.

PMID: 34642965 PMC: 9299162. DOI: 10.1111/ced.14979.